Loading clinical trials...
Loading clinical trials...
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3016859 for the Treatment of Chronic Low Back Pain
Conditions
Interventions
LY3016859
Placebo
Locations
34
United States
Simon Williamson Clinic
Birmingham, Alabama, United States
Synexus - US
Chandler, Arizona, United States
Synexus- Chandler
Chandler, Arizona, United States
Irvine Clinical Research Center
Irvine, California, United States
Artemis Institute for Clinical Research
Riverside, California, United States
Artemis Institute for Clinical Research
San Diego, California, United States
Start Date
August 25, 2020
Primary Completion Date
June 4, 2021
Completion Date
October 4, 2021
Last Updated
November 30, 2023
NCT05508360
NCT04658628
NCT05780021
NCT06080464
NCT06831994
NCT06106191
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions